Stock options lose favor, but still fuel big pay totals:
The numbers boggle the mind and dominate the pay totals. Last year, Eli Lilly and Co. boss Sidney Taurel received stock options that could balloon in value to $18 million over the next decade, even if the company’s shares underperform the stock market’s historical average return. The grant of options to buy 400,000 shares of stock accounted for nearly 80 percent of the $23 million in compensation doled out last year to Lilly’s chairman, CEO and president. Options made up…